Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Clinical trial NCT00421213 · COMPLETED

Trial details

NCT number: NCT00421213
Sponsor: Alaunos Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Neoplasms Bone Marrow Neoplasms Non-Hodgkin's Lymphoma

Start date: 2006-12-01
Primary completion: 2012-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.